Bristol-Myers Squibb Company (BMY)

Days of inventory on hand (DOH)

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Inventory turnover		12.42	10.53	12.16	14.80	5.68
DOH	days	29.38	34.66	30.01	24.66	64.30

December 31, 2024 calculation

DOH = 365 ÷ Inventory turnover
= 365 ÷ 12.42
= 29.38

Based on the provided data, Bristol-Myers Squibb Company's days of inventory on hand (DOH) have displayed fluctuations over the years. In 2020, the company had inventory on hand for an average of approximately 64.30 days, indicating a relatively high level of inventory relative to its sales.

However, in subsequent years, there was a notable improvement in inventory management efficiency. By the end of 2021, the DOH decreased significantly to 24.66 days, suggesting the company was able to reduce its inventory levels, potentially through better inventory control or increased sales turnover.

In 2022, the DOH increased slightly to 30.01 days, indicating a small uptick in inventory on hand compared to the previous year. This uptick was followed by further increases in 2023 and 2024, with DOH standing at 34.66 days and 29.38 days, respectively. These increases may suggest either a build-up of inventory relative to sales or a slowdown in sales turnover during these periods.

Overall, the trend in Bristol-Myers Squibb Company's DOH indicates a mix of inventory management effectiveness, sales performance, and operational efficiency. Further analysis comparing these figures to industry benchmarks and company strategies would provide a more comprehensive understanding of the company's inventory management practices.